Gabriel Fernando Esteves Cardia, PhD
Gabriel Fernando Esteves Cardia, PhD
Professional Profile
Gabriel Fernando Esteves Cardia is a researcher, professor, and health scientist whose academic trajectory connects Physical Education, Health Sciences, experimental pharmacology, inflammation, natural products, exercise physiology, and biological-response assessment.
His academic formation at the State University of Maringá combines undergraduate training in Physical Education with Master's and doctoral degrees in Health Sciences, providing an interdisciplinary foundation that links human physiology and health-related outcomes with experimental biomedical research.
His scientific work includes experimental investigation of inflammatory responses, oxidative injury, hepatotoxicity, pharmacological activity, essential oils, naturally derived compounds, and biological mechanisms associated with tissue protection and recovery.
His broader research trajectory also includes exercise-related health outcomes, quality-of-life assessment, epidemiological questions, and health-science studies involving clinical and population-level evidence.
This combination contributes an important biological and physiological perspective to the multidisciplinary structure of the Journal of Digital Health and Advanced Biomaterials (JDHAB).
Inflammation and Biological Response
A major component of Cardia's scientific activity concerns the mechanisms and experimental modulation of inflammatory responses.
His research has examined acute and systemic inflammatory models, leukocyte recruitment, inflammatory mediators, oxidative stress, tissue injury, and the pharmacological effects of naturally derived compounds.
These investigations contribute to understanding how candidate therapeutic substances may alter biological pathways associated with inflammation while also requiring careful assessment of dose, toxicity, tissue response, and experimental reproducibility.
His work therefore bridges pharmacological intervention with the measurement of biological response, an interface that is directly relevant to translational biomedical research.
Experimental Pharmacology
Cardia's research includes extensive participation in experimental pharmacology studies investigating the biological effects of natural compounds, essential oils, and pharmacologically active plant-derived substances.
Experimental models have been used to examine anti-inflammatory, hepatoprotective, gastroprotective, antioxidant, and related biological effects.
These studies require integration of pharmacological intervention with biochemical markers, histological or biological assessment, inflammatory-response measures, and controlled experimental models.
The resulting evidence contributes to the characterization of candidate bioactive compounds while maintaining the important distinction between effects observed in experimental models and therapeutic effectiveness established in human clinical settings.
Natural Products and Bioactive Compounds
Natural products constitute a recurring component of Cardia's scientific production.
His research includes essential oils and naturally occurring compounds such as citral, lavender-derived preparations, α-bisabolol, β-myrcene, and compounds associated with aromatic and medicinal plants.
These substances have been investigated in relation to inflammation, oxidative stress, hepatotoxicity, tissue injury, gastroprotection, and other biological outcomes.
The work emphasizes pharmacological characterization rather than assuming that natural origin itself establishes safety or therapeutic efficacy.
This distinction is relevant to biomedical research because naturally derived compounds require the same attention to experimental design, dose response, toxicity, biological mechanisms, and reproducibility as other candidate therapeutic agents.
Hepatoprotection and Oxidative Injury
A particularly visible line within Cardia's experimental research concerns pharmacological protection against chemically induced liver injury.
Several studies have used acetaminophen-induced hepatotoxicity as an experimental model for evaluating naturally derived compounds and essential oils.
These investigations examine the relationship among toxic exposure, oxidative stress, inflammatory response, biochemical markers, tissue damage, and the potential protective effects of pharmacologically active substances.
This work provides experience with experimental models in which biological protection must be demonstrated through convergent evidence rather than through a single biochemical or observational parameter.
Exercise Physiology and Health-Related Outcomes
Cardia's original training in Physical Education remains an important component of his broader scientific profile.
His work includes research involving physical exercise, resistance training, physiological adaptation, functional outcomes, and health-related quality of life.
These studies connect exercise prescription with the evaluation of measurable outcomes relevant to health, physical function, rehabilitation, and quality of life.
His interdisciplinary training allows exercise-related interventions to be interpreted within a broader Health Sciences framework, including physiological, pharmacological, behavioral, and epidemiological considerations.
Health Sciences and Epidemiological Research
In addition to experimental laboratory work, Cardia has participated in studies addressing epidemiological and public-health questions.
This includes research on cancer mortality and the use of population-level health data to examine disease patterns and health outcomes.
Such investigations complement his experimental trajectory by extending scientific analysis from biological mechanisms and controlled models toward population-level patterns and health-system questions.
The coexistence of experimental and epidemiological approaches contributes to a broader understanding of the levels of evidence through which biomedical and health-related questions may be investigated.
Academic Teaching and Interdisciplinary Health Sciences
Cardia is associated with the Department of Physical Education of the State University of Maringá, where his academic activities connect education, human physiology, exercise, and health sciences.
His research trajectory also reflects extensive collaboration with investigators working in pharmacology, therapeutics, inflammation, natural products, epidemiology, and related biomedical fields.
This collaborative environment supports an interdisciplinary perspective in which physical activity and human physiology coexist with experimental models of disease, pharmacological intervention, and biological measurement.
Editorial Role at JDHAB
As an Editorial Board Member of the Journal of Digital Health and Advanced Biomaterials, Gabriel Fernando Esteves Cardia contributes interdisciplinary expertise in inflammation, experimental pharmacology, exercise physiology, natural products, biological-response assessment, and Health Sciences.
His scientific background is particularly relevant to manuscripts involving biological evaluation of compounds and materials, inflammatory response, oxidative injury, tissue protection, physiological outcomes, and experimental models used to support biomedical claims.
His experience also supports critical consideration of the distinction between experimental pharmacological activity and evidence sufficient to establish clinical effectiveness.
Within JDHAB, his contribution therefore complements expertise in biomaterials, clinical sciences, pharmaceutical materials, digital health, and translational research by adding a physiological and pharmacological perspective on biological performance.
As an Editorial Board Member, his role supports the journal's scientific community and subject-matter expertise while remaining distinct from the routine manuscript decision-making responsibilities assigned to the journal's Associate Editors and editorial leadership.
Research and Scholarly Focus
Selected Scientific Contributions
Contribution to the JDHAB Scientific Scope
Cardia's profile strengthens the biological and Health Sciences dimensions of JDHAB by contributing expertise in inflammation, pharmacological response, physiology, natural products, and experimental models of tissue injury and protection.
His expertise is particularly relevant when biomaterials, pharmaceutical compounds, bioactive substances, or emerging technologies are accompanied by claims concerning anti-inflammatory activity, tissue protection, toxicity, biological compatibility, or therapeutic potential.
His experimental background supports critical assessment of whether biological claims are appropriately supported by the design, measurements, controls, and limitations of the underlying experimental model.
His work in exercise physiology and broader Health Sciences also provides a complementary perspective on functional outcomes, physiological responses, rehabilitation, and population-level health evidence.
This interdisciplinary contribution helps JDHAB maintain continuity between material or technological innovation and the biological evidence required to interpret its potential relevance to human health.
